Trials / Completed
CompletedNCT02290821
Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the analgesic efficacy of DSG 1% compared to placebo in the reduction of the pain associated with acute blunt trauma injuries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | |
| DRUG | Placebos |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2014-11-14
- Last updated
- 2017-04-19
- Results posted
- 2017-04-19
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02290821. Inclusion in this directory is not an endorsement.